Bobircă, A.; Bobircă, F.; Ancuta, I.; Florescu, A.; Pădureanu, V.; Florescu, D.N.; Pădureanu, R.; Florescu, A.; Mușetescu, A.E.
Rheumatic Immune-Related Adverse Events—A Consequence of Immune Checkpoint Inhibitor Therapy. Biology 2021, 10, 561.
https://doi.org/10.3390/biology10060561
AMA Style
Bobircă A, Bobircă F, Ancuta I, Florescu A, Pădureanu V, Florescu DN, Pădureanu R, Florescu A, Mușetescu AE.
Rheumatic Immune-Related Adverse Events—A Consequence of Immune Checkpoint Inhibitor Therapy. Biology. 2021; 10(6):561.
https://doi.org/10.3390/biology10060561
Chicago/Turabian Style
Bobircă, Anca, Florin Bobircă, Ioan Ancuta, Alesandra Florescu, Vlad Pădureanu, Dan Nicolae Florescu, Rodica Pădureanu, Anca Florescu, and Anca Emanuela Mușetescu.
2021. "Rheumatic Immune-Related Adverse Events—A Consequence of Immune Checkpoint Inhibitor Therapy" Biology 10, no. 6: 561.
https://doi.org/10.3390/biology10060561
APA Style
Bobircă, A., Bobircă, F., Ancuta, I., Florescu, A., Pădureanu, V., Florescu, D. N., Pădureanu, R., Florescu, A., & Mușetescu, A. E.
(2021). Rheumatic Immune-Related Adverse Events—A Consequence of Immune Checkpoint Inhibitor Therapy. Biology, 10(6), 561.
https://doi.org/10.3390/biology10060561
